Trial Profile
A multi-centre, randomized, open-label, study to compare conversion from calcineurin inhibitors to rapamune [sirolimus] versus standard therapy in established renal allograft recipients on maintenance therapy with mild to moderate renal insufficiency
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Mar 2011
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Ciclosporin; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Wyeth
- 03 Jun 2009 Results were published at the American Transplant Congress -- 9th Joint Congress of the American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation (AST).
- 31 May 2007 Status changed from in progress to completed.
- 10 May 2007 New trial record.